Trade

FDC Ltd share price

Balanced risk
  • 32%Low risk
  • 32%Moderate risk
  • 32%Balanced risk
  • 32%High risk
  • 32%Extreme risk
  • 430.45(-0.32%)
    July 10, 2026 15:24:45 PM IST
    • NSE
    • BSE
  • Vol : 179.11 K (NSE + BSE)
    Last 20 day avg : 293.63 K
FDC Ltd is trading -0.32% lower at Rs 430.45 as compared to its last closing price. FDC Ltd has been trading in the price range of 436.45 & 427.00. The company posted a net profit of 103.40 Crores in its last quarter.Listed peers of FDC Ltd include Cipla (-0.20%), Divi's Laboratories (0.31%), Sun Pharmaceutical Industries (-0.19%).The Mutual Fund holding in FDC Ltd was at 6.23% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in FDC Ltd was at 2.40% in 31 Mar 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jul 11, 2026, 09:36 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.88
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.01
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.38
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.59
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    26.24
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
427.00
Highest
436.45
52 week range
Lowest
314.75
Highest
528.30
FDC Ltd Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Cipla
1,438.75-0.201,16,228.7522.953.870.870.81
Divi's Laboratories
6,832.300.311,81,268.3278.6111.520.46-
Sun Pharmaceutical Industries
1,935.25-0.194,64,319.9636.245.770.920.50
Dr Reddy's Laboratories
1,245.50-1.911,03,954.0118.633.140.63-
Torrent Pharmaceuticals
4,895.20-0.031,65,669.1667.3217.10.8317.62
Mutual Fund Ownership
View all
Tata India Pharma & Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 20.69
  • % of AUM 1.68
ICICI Prudential ESG Exclusionary Strategy Fund Regular Growth
5/5
  • Amount Invested (Cr.) 24.55
  • % of AUM 1.61
ITI Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 3.42
  • % of AUM 1.55
ICICI Prudential MNC Fund Regular Growth
NA
  • Amount Invested (Cr.) 21.36
  • % of AUM 1.27
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 4.09
  • % of AUM 1.23
FDC Ltd Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-27Audited Results
2026-02-05Quarterly Results & Interim Dividend
2025-11-05Quarterly Results & Others
2025-08-07Quarterly Results
2025-05-28Audited Results
About the company FDC Ltd
  • IndustryBiotechnology & Drugs
  • ISININE258B01022
  • BSE Code531599
  • NSE Code
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
  • Management Info
  • Vishal ShahChief Financial Officer
  • Ameya ChandavarkarChief Executive Officer - International Business, Executive Director
  • Varsharani KatreCompliance Officer, Company Secretary
  • Mohan ChandavarkarManaging Director, Executive Director
  • Nandan ChandavarkarJoint Managing Director, Executive Director
  • Ashok ChandavarkarExecutive Director
FDC Ltd Share Price FAQs

FDC Ltd is trading at 430.45 as on Fri Jul 10 2026 09:54:45. This is -0.32% lower as compared to its previous closing price of 431.85.

The market capitalization of FDC Ltd is 7011.40 Cr as on Fri Jul 10 2026 09:54:45.

The 52 wk high for FDC Ltd is 528.30 whereas the 52 wk low is 314.75

FDC Ltd can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: %
  • D/E ratio: -

FDC Ltd reported a net profit of 281.42 Cr in 2026.

The Mutual Fund Shareholding was 6.23% at the end of 31 Mar 2026.